Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Aug 31, 2026 · Filed Sep 9, 2026
An Alterity Therapeutics director paid $24K out of pocket for Alterity Therapeutics shares. Shares held went up 33% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$23,810
Shares × reported transaction price
<$25K
+33.1%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
Closed at $4.49 on Aug 31, 2026, 54% above its 52-week low and 24% below its high, after a 5% drop over the previous 30 trading days
52-week range $2.92 (Dec 17, 2025) to $5.89 (Jul 6, 2026), 53% of the way up, from 248 adjusted closes. 30 trading days earlier: $4.74 on Jul 20, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −14.4% | −1.1% | −13.3% |
| 30 days | −30.8% | +2.1% | −32.9% |
Past results only. Not a forecast.
Insider filing
Traded Aug 31 · filed 9 days later
Not classified as an open-market trade.
Insider filing
Traded Aug 31 · filed 9 days later
Not classified as an open-market trade.
Insider filing
Traded Jun 15 · filed 9 days later
Compensation award — excluded from discretionary-purchase analysis.
